Filing Flows › Companies › Guardian Pharmacy Services › Cash flow
Guardian Pharmacy Services cash flow, quarter by quarter
Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$43.4M in Q3 2026 · $114M over twelve months
Analysis
In Q3 2026, Guardian Pharmacy Services generated $43.4M of operating cash flow. That is $19.2M more than in Q3 2025 ($24.2M).
Over the twelve months to Sep 30, 2026, operating cash flow was $114M; the largest uses were other financing ($31.7M), other investing ($24.7M), net borrowing (+) / repaid (−) ($4.3M); besides operations, cash came from shares issued ($30.3M); the cash balance rose by $83.2M.
Operating cash flow was $43.4M against net income of $19.1M — 2.3× profit, cash ran ahead of reported earnings. The largest differences: payables +$17.6M, inventory −$6.0M, depreciation & amortization +$5.9M.
Its cash conversion cycle was 6 days (receivables 26 + inventory 17 − payables 38).
Free cash flow
Cash runway and the debt wall
Guardian Pharmacy Services funds itself: free cash flow was $114M over the last twelve months, with $120M of cash and investments and no debt on the balance sheet.
Where the cash came from and went
From profit to cash
| Quarter | Receivable days | Inventory days | Payable days | Cash conversion cycle |
|---|---|---|---|---|
| Q3 2026 | 26 | 17 | 38 | 6 |
| Q2 2026 | 28 | 16 | 36 | 8 |
| Q1 2026 | 29 | 16 | 39 | 5 |
| Q4 2025 | 24 | 13 | 35 | 2 |
| Q3 2025 | 24 | 14 | 34 | 4 |
| Q2 2025 | 25 | 14 | 34 | 6 |
| Q1 2025 | 27 | 14 | 35 | 6 |
| Q4 2024 | 26 | 15 | 35 | 5 |
Every quarter
| Quarter | Operating cash flow | Capital spending | Net borrowing (+) / repaid (−) | Shares issued | Cash drawn (+) / kept (−) | Free cash flow |
|---|---|---|---|---|---|---|
| Q3 2026 | $43.4M | — | −$1.1M | — | −$29.8M | $43.4M |
| Q2 2026 | $30.0M | — | −$1.0M | — | −$24.9M | $30.0M |
| Q1 2026 | $6.1M | — | −$1.1M | $30.3M | $726K | $6.1M |
| Q4 2025 | $34.6M | −$495K | −$1.1M | — | −$29.1M | $34.1M |
| Q3 2025 | $28.2M | −$4.0M | −$1.1M | — | −$17.7M | $24.2M |
| Q2 2025 | $19.9M | — | −$1.1M | $29.0M | −$4.8M | $19.9M |
| Q1 2025 | $17.6M | — | −$1.1M | — | −$9.3M | $17.6M |
| Q4 2024 | $22.3M | −$2.2M | −$45.4M | — | $32.6M | $20.1M |
Guardian Pharmacy Services: income statement and cash flow
Guardian Pharmacy Services, Q3 2026: revenue $371M (-2% year over year), operating margin 6.8%. The chart follows the revenue to costs, profit and cash.
Guardian Pharmacy Services: every quarter, Q/Q and Y/Y → Open in the app
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.